Compare SRI & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRI | BDSX |
|---|---|---|
| Founded | 1965 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.7M | 153.3M |
| IPO Year | 1997 | 2020 |
| Metric | SRI | BDSX |
|---|---|---|
| Price | $6.93 | $21.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $16.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 312.4K | 80.7K |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $824,444,000.00 | $88,499,000.00 |
| Revenue This Year | N/A | $25.26 |
| Revenue Next Year | $4.73 | $19.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 18.46 | ★ 24.08 |
| 52 Week Low | $4.60 | $0.27 |
| 52 Week High | $9.71 | $24.92 |
| Indicator | SRI | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 44.79 | 63.64 |
| Support Level | $6.78 | $13.41 |
| Resistance Level | $7.45 | N/A |
| Average True Range (ATR) | 0.39 | 1.97 |
| MACD | -0.04 | 0.62 |
| Stochastic Oscillator | 17.89 | 71.05 |
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.